| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclosporin A binding | 2.14e-12 | 24 | 73 | 7 | GO:0016018 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 5.73e-10 | 50 | 73 | 7 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 8.76e-10 | 53 | 73 | 7 | GO:0016859 | |
| GeneOntologyMolecularFunction | amide binding | PPIAL4C IGF1R PPIAL4E PPIAL4H INSR PPIAL4A PPIAL4G CERT1 PPIC PPIAL4F | 1.32e-07 | 299 | 73 | 10 | GO:0033218 |
| GeneOntologyMolecularFunction | isomerase activity | 4.98e-07 | 192 | 73 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | insulin receptor activity | 3.95e-05 | 3 | 73 | 2 | GO:0005009 | |
| GeneOntologyMolecularFunction | insulin binding | 1.31e-04 | 5 | 73 | 2 | GO:0043559 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 1.31e-04 | 5 | 73 | 2 | GO:0004565 | |
| GeneOntologyMolecularFunction | galactosidase activity | 2.74e-04 | 7 | 73 | 2 | GO:0015925 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 5.21e-04 | 43 | 73 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.00e-03 | 13 | 73 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 1.34e-03 | 15 | 73 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.74e-03 | 65 | 73 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 2.17e-03 | 19 | 73 | 2 | GO:0005520 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.90e-11 | 38 | 71 | 7 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 6.58e-10 | 54 | 71 | 7 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein folding | 2.19e-05 | 246 | 71 | 7 | GO:0006457 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | MET PPIAL4C IGF1R PPIAL4E PPIAL4H INSR PPIAL4A PPIAL4G PPIC NOS2 PPIAL4F NAA16 | 1.14e-04 | 976 | 71 | 12 | GO:0018193 |
| GeneOntologyCellularComponent | insulin receptor complex | 7.38e-05 | 4 | 74 | 2 | GO:0005899 | |
| Domain | Cyclophilin-type_PPIase_CS | 7.67e-09 | 19 | 71 | 5 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 1.34e-08 | 21 | 71 | 5 | IPR024936 | |
| Domain | Cyclophilin-like_dom | 1.72e-08 | 22 | 71 | 5 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 1.72e-08 | 22 | 71 | 5 | PS50072 | |
| Domain | Pro_isomerase | 1.72e-08 | 22 | 71 | 5 | PF00160 | |
| Domain | - | 1.72e-08 | 22 | 71 | 5 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.72e-08 | 22 | 71 | 5 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 1.72e-08 | 22 | 71 | 5 | PS00170 | |
| Domain | Tyr_kinase_insulin-like_rcpt | 4.26e-05 | 3 | 71 | 2 | IPR016246 | |
| Domain | Furin-like | 2.96e-04 | 7 | 71 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.96e-04 | 7 | 71 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 2.96e-04 | 7 | 71 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 2.96e-04 | 7 | 71 | 2 | PF01030 | |
| Domain | - | 2.96e-04 | 7 | 71 | 2 | 3.80.20.20 | |
| Domain | PNT | 7.66e-04 | 11 | 71 | 2 | PS51433 | |
| Domain | Pointed_dom | 7.66e-04 | 11 | 71 | 2 | IPR003118 | |
| Domain | SAM_PNT | 7.66e-04 | 11 | 71 | 2 | PF02198 | |
| Domain | Tyr_kinase_rcpt_2_CS | 7.66e-04 | 11 | 71 | 2 | IPR002011 | |
| Domain | SAM_PNT | 7.66e-04 | 11 | 71 | 2 | SM00251 | |
| Domain | RECEPTOR_TYR_KIN_II | 9.18e-04 | 12 | 71 | 2 | PS00239 | |
| Domain | TPR | 1.48e-03 | 129 | 71 | 4 | SM00028 | |
| Domain | TPR_repeat | 1.65e-03 | 133 | 71 | 4 | IPR019734 | |
| Domain | TPR-like_helical_dom | 1.93e-03 | 233 | 71 | 5 | IPR011990 | |
| Domain | Furin_repeat | 2.10e-03 | 18 | 71 | 2 | IPR006212 | |
| Domain | FU | 2.10e-03 | 18 | 71 | 2 | SM00261 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF512B ZXDC ZNF596 ZNF335 PLAG1 PLAGL2 ZNF749 ZNF101 ZNF681 | 2.59e-03 | 775 | 71 | 9 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF512B ZXDC ZNF596 ZNF335 PLAG1 PLAGL2 ZNF749 ZNF101 ZNF681 | 2.64e-03 | 777 | 71 | 9 | PS00028 |
| Domain | Znf_C2H2-like | ZNF512B ZXDC ZNF596 ZNF335 PLAG1 PLAGL2 ZNF749 ZNF101 ZNF681 | 3.10e-03 | 796 | 71 | 9 | IPR015880 |
| Domain | Znf_C2H2 | ZNF512B ZXDC ZNF596 ZNF335 PLAG1 PLAGL2 ZNF749 ZNF101 ZNF681 | 3.34e-03 | 805 | 71 | 9 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF512B ZXDC ZNF596 ZNF335 PLAG1 PLAGL2 ZNF749 ZNF101 ZNF681 | 3.42e-03 | 808 | 71 | 9 | SM00355 |
| Domain | C2H2_Znf_fam | 3.73e-03 | 24 | 71 | 2 | IPR027775 | |
| Domain | - | 4.14e-03 | 679 | 71 | 8 | 3.30.160.60 | |
| Domain | TyrKc | 4.59e-03 | 88 | 71 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 4.59e-03 | 88 | 71 | 3 | IPR020635 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.72e-03 | 694 | 71 | 8 | IPR013087 | |
| Domain | TPR_1 | 4.88e-03 | 90 | 71 | 3 | PF00515 | |
| Domain | TPR_1 | 4.88e-03 | 90 | 71 | 3 | IPR001440 | |
| Domain | ETS_DOMAIN_1 | 5.05e-03 | 28 | 71 | 2 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 5.05e-03 | 28 | 71 | 2 | PS00346 | |
| Domain | ETS | 5.05e-03 | 28 | 71 | 2 | SM00413 | |
| Domain | Ets_dom | 5.05e-03 | 28 | 71 | 2 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 5.05e-03 | 28 | 71 | 2 | PS50061 | |
| Domain | Ets | 5.05e-03 | 28 | 71 | 2 | PF00178 | |
| Domain | PROTEIN_KINASE_TYR | 6.01e-03 | 97 | 71 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.01e-03 | 97 | 71 | 3 | IPR008266 | |
| Domain | - | 7.22e-03 | 746 | 71 | 8 | 3.40.50.300 | |
| Domain | - | 7.68e-03 | 106 | 71 | 3 | 1.10.150.50 | |
| Domain | Laminin_EGF | 7.82e-03 | 35 | 71 | 2 | PF00053 | |
| Domain | EGF_Lam | 7.82e-03 | 35 | 71 | 2 | SM00180 | |
| Domain | - | 7.82e-03 | 35 | 71 | 2 | 3.20.20.80 | |
| Domain | - | 7.99e-03 | 207 | 71 | 4 | 1.25.40.10 | |
| Domain | Glyco_hydro_catalytic_dom | 9.17e-03 | 38 | 71 | 2 | IPR013781 | |
| Pubmed | 3.69e-08 | 4 | 74 | 3 | 24973425 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19139090 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22081023 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22438913 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 35964946 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12813019 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21474992 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28050756 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24072183 | ||
| Pubmed | Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. | 4.47e-06 | 2 | 74 | 2 | 16642022 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28407051 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26438154 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 38383709 | ||
| Pubmed | Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. | 4.47e-06 | 2 | 74 | 2 | 23671263 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24809298 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16891453 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31088290 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19381485 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26862994 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18708119 | ||
| Pubmed | A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. | 4.47e-06 | 2 | 74 | 2 | 21139139 | |
| Pubmed | The insulin and IGF1 receptor kinase domains are functional dimers in the activated state. | 4.47e-06 | 2 | 74 | 2 | 25758790 | |
| Pubmed | Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. | 4.47e-06 | 2 | 74 | 2 | 16644916 | |
| Pubmed | Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis. | 4.47e-06 | 2 | 74 | 2 | 28248553 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 1660482 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25194880 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25246545 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27384680 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 35786404 | ||
| Pubmed | Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. | 4.47e-06 | 2 | 74 | 2 | 27207510 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28138037 | ||
| Pubmed | Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function. | 4.47e-06 | 2 | 74 | 2 | 27207537 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21729677 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28418902 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30070361 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25017244 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18711691 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31562314 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27088794 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 14722023 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17416680 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22692545 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26850678 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21177763 | ||
| Pubmed | Insulin, insulin receptor and insulin-like growth factor-I receptor on the human ocular surface. | 4.47e-06 | 2 | 74 | 2 | 12613967 | |
| Pubmed | Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. | 4.47e-06 | 2 | 74 | 2 | 18693051 | |
| Pubmed | Signalling through the insulin receptor and the insulin-like growth factor-I receptor. | 4.47e-06 | 2 | 74 | 2 | 7821728 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21908557 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 10704859 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19817984 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19744489 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30500808 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19666492 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28065828 | ||
| Pubmed | Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors. | 4.47e-06 | 2 | 74 | 2 | 26063314 | |
| Pubmed | Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. | 4.47e-06 | 2 | 74 | 2 | 30765523 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24302626 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26251471 | ||
| Pubmed | Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis. | 4.47e-06 | 2 | 74 | 2 | 25981038 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22879999 | ||
| Pubmed | Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling. | 4.47e-06 | 2 | 74 | 2 | 36548088 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17189427 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21524684 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23873272 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25916750 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22541124 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22825921 | ||
| Pubmed | A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. | 4.47e-06 | 2 | 74 | 2 | 7895674 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19851056 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28030849 | ||
| Pubmed | Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds. | 4.47e-06 | 2 | 74 | 2 | 28468775 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19835884 | ||
| Pubmed | Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. | 4.47e-06 | 2 | 74 | 2 | 33275876 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20620597 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19406949 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27905925 | ||
| Pubmed | Regulation of upstream binding factor 1 activity by insulin-like growth factor I receptor signaling. | 4.47e-06 | 2 | 74 | 2 | 15533945 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19524295 | ||
| Pubmed | ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors. | 4.47e-06 | 2 | 74 | 2 | 26122367 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15063759 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18650937 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 34074726 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30213860 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22161861 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17641087 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32975906 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 29040448 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24970814 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28096258 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28830678 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31908002 | ||
| Pubmed | Insulin receptor-related receptor as an extracellular alkali sensor. | 1.34e-05 | 3 | 74 | 2 | 21641549 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 35921893 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 29045907 | ||
| Pubmed | MicroRNA 322 Aggravates Dexamethasone-Induced Muscle Atrophy by Targeting IGF1R and INSR. | 1.34e-05 | 3 | 74 | 2 | 32046161 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 16831875 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 26475121 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 25269484 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 32979864 | ||
| Pubmed | Insulin regulates neurovascular coupling through astrocytes. | 1.34e-05 | 3 | 74 | 2 | 35858325 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 5.00e-05 | 404 | 74 | 6 | chr1q21 | |
| Cytoband | 1q21.2 | 2.12e-04 | 71 | 74 | 3 | 1q21.2 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.52e-04 | 40 | 47 | 3 | 321 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.74e-04 | 718 | 47 | 8 | 28 | |
| GeneFamily | ETS transcription factor family | 2.39e-03 | 28 | 47 | 2 | 534 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.32e-03 | 115 | 47 | 3 | 769 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.06e-06 | 160 | 74 | 5 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.69e-06 | 167 | 74 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 177 | 74 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 181 | 74 | 5 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-05 | 181 | 74 | 5 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 183 | 74 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 183 | 74 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-05 | 183 | 74 | 5 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 1.46e-05 | 186 | 74 | 5 | a16ecf70271894a842925f232009e2623d16947e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 187 | 74 | 5 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 187 | 74 | 5 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-05 | 189 | 74 | 5 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 190 | 74 | 5 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.62e-05 | 190 | 74 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 190 | 74 | 5 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 190 | 74 | 5 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 191 | 74 | 5 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.70e-05 | 192 | 74 | 5 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 193 | 74 | 5 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.98e-05 | 198 | 74 | 5 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | Biopsy_IPF-Endothelial-Lymphatic_Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 2.02e-05 | 199 | 74 | 5 | 483b01f1308eb201a1ff3788fe656c486b6b9e66 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.02e-05 | 199 | 74 | 5 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 74 | 5 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-04 | 159 | 74 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.46e-04 | 160 | 74 | 4 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.46e-04 | 160 | 74 | 4 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 161 | 74 | 4 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 161 | 74 | 4 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-04 | 166 | 74 | 4 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 167 | 74 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 168 | 74 | 4 | c833e3311af2582787d3ff2ad59d802fff865f8f | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-04 | 168 | 74 | 4 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 172 | 74 | 4 | 001d2553a0b5dae3269727bda8ef8067deebab0d | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.10e-04 | 176 | 74 | 4 | 9a4cef3dc88f64a71b91ab4790ea19334afee3ee | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 2.15e-04 | 177 | 74 | 4 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 178 | 74 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 178 | 74 | 4 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 2.24e-04 | 179 | 74 | 4 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | Endothelial|World / shred by cell class for turbinate | 2.24e-04 | 179 | 74 | 4 | 052b2681974be00efb8503fa4e2c85d91d5ebd06 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 179 | 74 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 179 | 74 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-04 | 180 | 74 | 4 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.34e-04 | 181 | 74 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-04 | 181 | 74 | 4 | 7d7d1edeae4e0ebe40b324d1231cd26e27ba9d42 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-04 | 181 | 74 | 4 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 181 | 74 | 4 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.39e-04 | 182 | 74 | 4 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 182 | 74 | 4 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 182 | 74 | 4 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 182 | 74 | 4 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-04 | 183 | 74 | 4 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-04 | 183 | 74 | 4 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-04 | 183 | 74 | 4 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 183 | 74 | 4 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-04 | 183 | 74 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 15cbddea9efb2346a2028d77edfe9ba32923568f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 0087c605c161fd8a39aa394f51994a04e8353bf1 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 968afa6b5ba84169377a24c150bb68749fa674d9 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 920f95625978132c2b6c76654ef6298244103e2d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-04 | 185 | 74 | 4 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.54e-04 | 185 | 74 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 2.54e-04 | 185 | 74 | 4 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.54e-04 | 185 | 74 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 185 | 74 | 4 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 186 | 74 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 186 | 74 | 4 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.65e-04 | 187 | 74 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.65e-04 | 187 | 74 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.65e-04 | 187 | 74 | 4 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.70e-04 | 188 | 74 | 4 | e711c7a46d7cfa030ca2982eacc1dae5af5788dd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-04 | 188 | 74 | 4 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | droplet-Lung-1m-Epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-04 | 189 | 74 | 4 | 72ecd5a10e419bac475e22f5b602e7f008835ce9 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.76e-04 | 189 | 74 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.76e-04 | 189 | 74 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.76e-04 | 189 | 74 | 4 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-04 | 189 | 74 | 4 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.81e-04 | 190 | 74 | 4 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 190 | 74 | 4 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 190 | 74 | 4 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 190 | 74 | 4 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-04 | 191 | 74 | 4 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-04 | 192 | 74 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.99e-04 | 193 | 74 | 4 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.99e-04 | 193 | 74 | 4 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 193 | 74 | 4 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A | 2.47e-06 | 197 | 70 | 7 | 1311_DN | |
| Drug | Insulin Glargine | 9.32e-06 | 2 | 70 | 2 | ctd:D000069036 | |
| Drug | Insulin Lispro | 9.32e-06 | 2 | 70 | 2 | DB00046 | |
| Drug | Insulin Glargine | 9.32e-06 | 2 | 70 | 2 | DB00047 | |
| Drug | geldanamycin | 1.80e-05 | 371 | 70 | 8 | ctd:C001277 | |
| Disease | gastroschisis (biomarker_via_orthology) | 1.39e-05 | 3 | 64 | 2 | DOID:11044 (biomarker_via_orthology) | |
| Disease | gastrinoma (is_marker_for) | 1.39e-05 | 3 | 64 | 2 | DOID:5577 (is_marker_for) | |
| Disease | Extra-osseous Ewing's sarcoma | 2.77e-05 | 4 | 64 | 2 | C0279980 | |
| Disease | gestational diabetes (biomarker_via_orthology) | 4.61e-05 | 5 | 64 | 2 | DOID:11714 (biomarker_via_orthology) | |
| Disease | neutropenia, response to metamizole, Drug-induced agranulocytosis | 6.91e-05 | 6 | 64 | 2 | EFO_0010971, HP_0012235, MONDO_0001475 | |
| Disease | Developmental delay (disorder) | 7.17e-05 | 37 | 64 | 3 | C0424605 | |
| Disease | Lewy body dementia (is_implicated_in) | 9.66e-05 | 7 | 64 | 2 | DOID:12217 (is_implicated_in) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.28e-04 | 224 | 64 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | Intestinal Diseases | 1.29e-04 | 8 | 64 | 2 | C0021831 | |
| Disease | Ewings sarcoma | 1.29e-04 | 8 | 64 | 2 | C0553580 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.65e-04 | 9 | 64 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | sleep disorder (implicated_via_orthology) | 2.52e-04 | 11 | 64 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 2.52e-04 | 11 | 64 | 2 | OBA_2045197 | |
| Disease | dementia (is_implicated_in) | 3.01e-04 | 12 | 64 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 4.14e-04 | 14 | 64 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 4.77e-04 | 15 | 64 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | albumin:globulin ratio measurement | 5.43e-04 | 73 | 64 | 3 | EFO_0005128 | |
| Disease | pulmonary function measurement | 6.35e-04 | 77 | 64 | 3 | EFO_0003892 | |
| Disease | Congenital hernia of foramen of Morgagni | 7.73e-04 | 19 | 64 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 7.73e-04 | 19 | 64 | 2 | C0265700 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 8.58e-04 | 20 | 64 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Fetal Growth Retardation | 8.58e-04 | 20 | 64 | 2 | C0015934 | |
| Disease | Kidney Diseases | 9.36e-04 | 88 | 64 | 3 | C0022658 | |
| Disease | Congenital diaphragmatic hernia | 9.47e-04 | 21 | 64 | 2 | C0235833 | |
| Disease | Lewy Body Disease | 1.04e-03 | 22 | 64 | 2 | C0752347 | |
| Disease | Neoplasm Metastasis | 1.28e-03 | 217 | 64 | 4 | C0027627 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.35e-03 | 220 | 64 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.46e-03 | 26 | 64 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | 1.53e-03 | 1015 | 64 | 8 | EFO_0004533 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.69e-03 | 28 | 64 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.69e-03 | 108 | 64 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.82e-03 | 239 | 64 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | Drug habituation | 2.02e-03 | 115 | 64 | 3 | C0013170 | |
| Disease | Drug abuse | 2.02e-03 | 115 | 64 | 3 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.02e-03 | 115 | 64 | 3 | C4316881 | |
| Disease | Substance-Related Disorders | 2.02e-03 | 115 | 64 | 3 | C0236969 | |
| Disease | Drug Use Disorders | 2.02e-03 | 115 | 64 | 3 | C0013222 | |
| Disease | Drug Dependence | 2.02e-03 | 115 | 64 | 3 | C1510472 | |
| Disease | Substance Dependence | 2.02e-03 | 115 | 64 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 2.02e-03 | 115 | 64 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.02e-03 | 115 | 64 | 3 | C0029231 | |
| Disease | uric acid measurement | 2.07e-03 | 610 | 64 | 6 | EFO_0004761 | |
| Disease | Substance abuse problem | 2.07e-03 | 116 | 64 | 3 | C0740858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SDFLMKRLQKGQKYF | 51 | O43768 | |
| EKEALKGKSFHMFIY | 56 | Q14507 | |
| NIMTKVHGKRYAYKF | 376 | P11308 | |
| SHRMKAVDFYSGKVK | 791 | Q4L235 | |
| FKLAQTYMDKLSKHG | 186 | Q92624 | |
| KGKMKHSQAKRYLFS | 221 | Q9ULI1 | |
| LHKTEFLGKEMKLYF | 126 | P53805 | |
| ESSMKNSFGLKYLHK | 211 | Q3YEC7 | |
| YKNAMTELKKKSHFG | 291 | Q9Y5P4 | |
| FIIYRHKQKGKESSM | 876 | Q96KG7 | |
| KFLFKTKFHQYAMNG | 6 | P35228 | |
| NGYSHLGKKKRMRSF | 86 | Q9C0D6 | |
| AMEHFGYRNSKTSKK | 141 | A0A0B4J2A2 | |
| KYVFRMQKYHKSNGG | 1056 | Q6P0N0 | |
| FLNKMRIYDGKKHFI | 226 | O15480 | |
| HAMRGRLFYTAKAKK | 271 | Q9P1W3 | |
| HRNLTIKAGKMYFAF | 436 | P08069 | |
| LFAVYHMKSAEGRKK | 221 | Q8NGY9 | |
| FYMKAKIYKHIGNLK | 411 | Q6N069 | |
| KNRVHYMKFTKGKDL | 121 | Q96BK5 | |
| GMAYLNAKKFVHRDL | 1146 | P06213 | |
| AMEHFGYRNSKTSKK | 141 | P0DN26 | |
| EKMLANFESGKHKYR | 586 | Q9BUQ8 | |
| KRFFVLDNGMLKYSK | 106 | Q9BZF3 | |
| AMEHFGYRNSKTSKK | 141 | A0A075B759 | |
| MLYKDFFKGKTVFNH | 166 | Q16827 | |
| TLYKLGFFKRHYKEM | 1121 | Q13349 | |
| AMEHFGYRNSKTSKK | 141 | A0A075B767 | |
| AMEHFGYRNSKTSKK | 141 | Q9Y536 | |
| AMEHFGYRNSKTSKK | 141 | P0DN37 | |
| MKIFHKKFGLHNFRT | 656 | P54132 | |
| HSYDSLFRKKQKGMV | 206 | Q9H227 | |
| NIMTKVHGKRYAYKF | 346 | Q01543 | |
| LMKAFIFKYSAKTGL | 326 | P25106 | |
| KVRAGDNKYMHLKVF | 56 | P01040 | |
| FVAFHINKGLVKKYM | 71 | O60427 | |
| YIHNFKVLQAAFKKM | 71 | Q9UPY8 | |
| FARFVAMKYIKSNSK | 131 | Q7Z4H7 | |
| KYMHKDAKKGFIRLD | 396 | Q9H078 | |
| KNFRIYSLDMKKSFF | 516 | Q8IW92 | |
| LLKGKMKVSYRGHFL | 176 | Q8NE79 | |
| FKAFYVHKFRAMLGK | 51 | Q2VPK5 | |
| HLEAFVAKFMALYKK | 331 | P40938 | |
| YMFNVGHKKLKIRSQ | 1531 | Q16363 | |
| FIYSLRNKDMKGALK | 286 | Q8NGS0 | |
| LFAVYHMHSKEGRKK | 221 | Q8N349 | |
| GMKYLASKKFVHRDL | 1191 | P08581 | |
| GYKGSKFHRVIKDFM | 81 | P45877 | |
| HGKLVNDKFTRMYFK | 451 | Q7L1I2 | |
| GFKRFKYSKFSHMHL | 301 | Q1RMZ1 | |
| KSLKFTRMQKAGFLY | 281 | P04053 | |
| MPFGNTHNKFKLNYK | 1 | P06732 | |
| KNSFKGQYKHMHRTK | 1461 | Q5K651 | |
| SLNHKAYRDAFKKMK | 476 | Q92565 | |
| KGLKFRYQDHTFLKM | 1436 | O60287 | |
| GKAFASKYKLYRHMA | 76 | Q9UPG8 | |
| GSFNYLKFFKHIRKL | 36 | A0A1B0GWK0 | |
| MSKHNLGIFYFKKAL | 306 | Q9H9A5 | |
| KAFVSKYKLQRHMAT | 71 | Q6DJT9 | |
| ANLMKQGKYRHFFEA | 346 | Q96N96 | |
| MLYKGLTFFHRGLLK | 286 | Q8NBP0 | |
| ITYMRTKHFVSKKFG | 131 | Q8TC21 | |
| GKKFTTVYNLKAHMK | 246 | Q2QGD7 | |
| CGKFFMYNSKLIRHQ | 331 | O43361 | |
| YKHALVNKMYGRGLK | 1186 | P29144 | |
| DSINRMKAYAFHQKK | 186 | Q9H788 | |
| KYCYSGLRKKAFVHM | 76 | Q2KHR2 | |
| RKGHIKLAKFGLYHM | 126 | Q8TEA7 | |
| KRAIMHSKNGKFLYF | 476 | O14512 | |
| RKQFKSKAGLNYHTM | 546 | Q96KM6 | |
| FFRKHGKMHTGEKRY | 211 | Q8IZC7 | |
| KYMKIFHKFSNLNGH | 146 | Q96N22 | |
| KLYHKKIFRTAMLFQ | 1011 | Q96QU8 | |
| RFFMEKRAKYAKLHP | 121 | P17480 | |
| GKSFKKRYTFKMHLL | 596 | Q9H4Z2 | |
| MVLKFGKKARKFAAY | 196 | Q96M32 |